Gadolinium and malaise Patient Reports February 11, 2012
Gadolinium Side Effects Report #5619565-7
Gadolinium side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Female patient, 56 years of age, weighting 245.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: dyspnoea, gait disturbance, malaise, musculoskeletal chest pain, oedema peripheral, pain in extremity, pelvic pain
, skin burning sensation, skin inflammation. Gadolinium dosage: unknown. Patient recovered.Gadolinium Side Effects Report #5912350-8
Gadolinium side effect was reported by a Health Professional from UNITED STATES on Oct 07, 2008. Female patient, 37 years of age, weighting 138.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: heart rate increased, hypoaesthesia, infusion site pain, malaise, nausea
, nerve injury, oedema peripheral, paraesthesia, skin discolouration. Gadolinium dosage: unknown. Patient was hospitalized. Patient recovered.Gadolinium Side Effects Report #5238074-0
Gadolinium side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Male patient, 63 years of age, weighting 186.0 lb, was diagnosed with cerebrovascular accident and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: hand deformity, limb discomfort, lung disorder, malaise. Gadolinium dosage: unknown. Patient was hospitalized. Patient recovered.
Gadolinium Side Effects Report #5626108-0
Gadolinium side effect was reported by a Pharmacist from UNITED STATES on Feb 13, 2008. Male patient, weighting 183.9 lb, was treated with Gadolinium. After drug was administered, patient experienced the following side effects: malaise, nausea
. Gadolinium dosage: 10ML. Patient recovered.
Gadolinium and malaise 